Odyssey Health (ODYY) EBIT Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 34.83% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 35.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 35.22% |
| Jan 31, 2026 | 50.35% |
| Oct 31, 2025 | 47.35% |
| Jul 31, 2025 | 56.06% |
| Apr 30, 2025 | 64.43% |
| Jan 31, 2025 | 57.05% |
| Oct 31, 2024 | 25.99% |
| Jul 31, 2024 | 27.88% |
| Apr 30, 2024 | 68.66% |
| Jan 31, 2024 | -22.23% |
| Oct 31, 2023 | 12.89% |
| Jul 31, 2023 | 17.26% |
| Apr 30, 2023 | -8.05% |
| Jan 31, 2023 | -43.81% |
| Oct 31, 2022 | -16.25% |
| Jul 31, 2022 | 57.19% |
| Apr 30, 2022 | -298.82% |
| Jan 31, 2022 | -180.26% |
| Oct 31, 2021 | -201.02% |
| Jul 31, 2021 | -217.08% |